🔆 📖 👤

Statutory Instruments

2024 No. 838

National Health Service, England

The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2024

Made

at 10.30 a.m. on 30th July 2024

Laid before Parliament

at 1.15 p.m. on 30th July 2024

Coming into force

1st September 2024

The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 164(8A)(a), (8B)(b) and (8D) and 272(7) and (8) of the National Health Service Act 2006( 1 ).

Citation, commencement, extent and application

1. —(1) These Regulations may be cited as the National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2024.

(2) These Regulations come into force on 1st September 2024.

(3) These Regulations extend to England and Wales and apply in relation to England only( 2 ).

Amendment of regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013

2. —(1)Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013( 3 ) (zero or nominal product reimbursement for coronavirus vaccines and antivirals) is amended as follows.

(2) In its heading, omit “coronavirus”.

(3) In paragraph (2)—

(a) in sub-paragraph (a), omit “(“a coronavirus vaccine”)”;

(b) omit “or” at the end of sub-paragraph (a); and

(c) after sub-paragraph (a) insert—

(aa) a drug or medicine which is used for vaccinating or immunising people against respiratory syncytial virus, if the conditions set out in paragraph (3) are satisfied;

(ab) a drug or medicine which is used for vaccinating or immunising people against measles, mumps and rubella, if the conditions set out in paragraph (3) are satisfied; or .

(4) In paragraph (3)—

(a) in sub-paragraphs (a) to (c), for “coronavirus” substitute “the” at each place where it occurs (three times); and

(b) in sub-paragraph (d), omit “coronavirus”.

(5) After paragraph (3), insert—

(3A) The references in paragraph (3) to vaccines or the vaccine in question are references to the drugs or medicines in respect of which the conditions set out in paragraph (3) are to be satisfied by virtue of paragraph (2)(a) to (ab). .

Signed by authority of the Secretary of State for Health and Social Care

Stephen Kinnock

Minister of State

Department of Health and Social Care

At 10.30 a.m. on 30th July 2024

( 1 )

2006 c. 41 . In section 164, subsections (8A) to (8E) were inserted by the Health Service Medical Supplies (Costs) Act 2017 (c. 23) , section 1, and subsections (8A) and (8D) were thereafter amended by the Health and Care Act 2022 (c. 31) , section 161(1)(a) to (c). See section 275(1) of the National Health Service Act 2006 for the meanings given to “prescribed” and “regulations” which are relevant to the powers being exercised.

( 2 )

See section 271(1) of the National Health Service Act 2006, by virtue of which the functions of the Secretary of State being exercised in the making of these Regulations are exercisable only in relation to England.

( 3 )

S.I. 2013/349 ; regulation 91A was inserted by S.I. 2022/930 .

Status: This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2024 (2024/838)

Displaying information

Status of this instrument

footnotecommentarytransitional and savingsin force statusrelated provisionsgeo extentinsert/omitsource countin force adj
Defined TermSection/ArticleIDScope of Application
a coronavirus vaccinereg. 2.(“_prnRfDs3

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.